Autor: |
Fasero, Maria, Quereda, Francisco, Andraca, Leire, Coronado, Pluvio J., Mendoza, Nicolas, Ramírez, Isabel, de la Viuda, Esther, Coronado, Pluvio, Baquedano, Laura, Llaneza, Placido, Nieto, Veronica, Otero, Borja, Sanchez-Mendez, Sonia, Alvarez de Frutos, Visitacion, Andraca, Leire, Barriga, Patricio, Benítez, Zully, Bombas, Teresa, Jesús Cancelo, María J., Cano, Antonio, Branco, Camil Castelo, Correa, Marta, Doval, Jose Luis, Fasero, Maria, Fiol, Gabriel, Garello, Nestor C., Genazzani, Andrea R., Gomez, Ana Isabel, Gomez, Maria A, Gonzalez, Silvia, Goulis, Dimitrios G., Guinot, Misericordia, Hernandez, Luis R., Herrero, Sonia, Iglesias, Eva, Jurado, Ana Rosa, Lete, Inaki, Lubian, Daniel, Martínez, Milagros, Nieto, Anibal, Nieto, Laura, Palacios, Santiago, Pedreira, Milagros, Perez-Campos, Ezequiel, Pla, María J., Presa, Jesús, Quereda, Francisco, Ribes, Miriam, Romero, Pablo, Roca, Beatriz, Sanchez-Capilla, Antonio, Sanchez-Borrego, Rafael, Santaballa, Ana, Santamaría, Amparo, Simoncini, Tommaso, Tinahones, Francisco, Calaf, Joaquín |
Zdroj: |
Menopause; August 2023, Vol. 30 Issue: 8 p873-880, 8p |
Abstrakt: |
The available evidence of hormone therapy interactions with other drugs comes mainly from biological plausibility, the knowledge of extensive concomitant use without reported incidents, and the extrapolation of hormonal contraception. These eligibility criteria can help in the decision process of hormone therapy coadministration with another group of drugs. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|